Evidence-Based Communication in Clinical, Mass Media, and Social Media Contexts to Enhance Informed Consent for Participation in Clinical Trials and Precision Medicine Initiatives

Susan E. Morgan, Aurora Occa, Wei Peng, Soroya J. McFarlane

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

9 Scopus citations

Abstract

This chapter explains that improved clinical trial communication will result in better informed patients who demonstrate greater willingness to participate in a system that is intended to produce significant advances in medical treatment. It centers on the factors where communication scholars and practitioners can best apply their energy and insights. These includes clinical communication interventions, including training of physicians, study nurses, and clinical research staff; public communication messages designed to inform a broad audience about scientific concepts that are central to meaningful and informed consent; and the use of social media platforms for participant recruitment and retention. The chapter discusses the implications of these findings for the development of new interventions designed to enroll members of the public in emerging precision medicine (PM) initiatives, particularly among minority populations. It also reviews communication-based interventions, including interpersonal communication trainings, public communication campaigns, persuasive message design, and targeted message delivery.

Original languageEnglish
Title of host publicationThe Handbook of Applied Communication Research
Subtitle of host publicationVolume 1: Volume 2
Pages897-915
Number of pages19
Volume1-2
ISBN (Electronic)9781119399926
DOIs
StatePublished - Jan 1 2020

Bibliographical note

Publisher Copyright:
© 2020 John Wiley and Sons, Inc. Published 2020 by John Wiley and Sons, Inc.

ASJC Scopus subject areas

  • General Arts and Humanities
  • General Social Sciences

Fingerprint

Dive into the research topics of 'Evidence-Based Communication in Clinical, Mass Media, and Social Media Contexts to Enhance Informed Consent for Participation in Clinical Trials and Precision Medicine Initiatives'. Together they form a unique fingerprint.

Cite this